Jun Jiang
6 Papers
Jun Jiang is an academic researcher. The author has contributed to research in topics: Medicine & Chemistry. The author has an hindex of 2, co-authored 6 publications.
Chat about Author
Papers
Downregulation of macrophage migration inhibitory factor attenuates NLRP3 inflammasome mediated pyroptosis in sepsis-induced AKI
Tianlong Li,Haibing Sun,Yiming Li,Lianjiu Su,Jun Jiang,Ye Liu,Nanhui Jiang,Rong Huang,Jiahao Zhang,Zhiyong Peng +9 more
TL;DR: In this article , the authors investigated the mechanism of MIF promoting pyroptosis in sepsis-induced AKI and showed that up-regulation of mIF in kidney tissue of mice with CLP (cecum ligation puncture) surgery and in LPS-injured human kidney-2 (HK-2) cells.
LncRNAs associated with oxidative stress in diabetic wound healing: Regulatory mechanisms and application prospects
TL;DR: In this paper , the authors reviewed the mechanisms of long noncoding RNAs related to oxidative stress in several stages of diabetic wound healing and discussed diagnostic and treatment potential of lncRNAs to treat diabetic wounds by improving oxidative stress.
OIP5-AS1 Inhibits Oxidative Stress and Inflammation in Ischemic Stroke Through miR-155-5p/IRF2BP2 Axis
TL;DR: OIP5-AS1 suppressed oxidative stress and inflammatory response to alleviate cell injury caused by OGD/R induction in HMC3 and SH-SY5Y cells through regulating miR-155-5p/IRF2BP2 axis, which might offer novel targeted molecules for ischemic stroke therapy.
5
LncRNA XIST Exacerbates Oxygen-Glucose Deprivation/Reoxygenation-Induced Cerebral Injury Through the miR-25-3p/TRAF3 Axis.
TL;DR: Importantly, silencing of XIST and overexpression of miR-25-3p reduced apoptosis and inflammatory response following OGD/R and the knockdown of TRAF3 ameliorated OGd/R-induced injury.
5
P311 knockdown alleviates hyperoxia-induced injury by inactivating the Smad3 signaling pathway in type II alveolar epithelial cells
TL;DR: Results indicate that P311 knockdown may be a novel target for the treatment of hyperoxia-induced lung injury and even bronchopulmonary dysplasia (BPD) by inhibiting the Smad3 signaling pathway in rat AEC II.